Docoh
Loading...

FATE Fate Therapeutics

News

Pro users get this 30m faster
3 Biotech Stocks to Watch Now
12 Oct 21
Biotech, Penny Stocks, Small Cap, Trading Ideas, General
Biotech companies develop new medicines, vaccines, or medical devices. They use advanced technologies and medical science to do so. Most biotech stocks trade at low prices and with a successful FDA approval or even promising news can send these stocks sky-high overnight.
Fate Therapeutics Sponsored Study Titled 'FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors' Posted To ClinicalTrials.Gov; Study Not Yet Recruiting
6 Oct 21
News, FDA
https://clinicaltrials.gov/ct2/show/NCT05069935
Fate Therapeutics Announces Publication Of FT538 Preclinical Data Demonstrating Enhanced Serial Killing And Functional Persistence Without Cytokine Support
15 Sep 21
News, FDA
Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, announced today the publication of
Cathie Wood's ARK Invest Posts Fund Purchases For Wednesday, Sept. 8, 2021: PATH, NVTA, FATE, PD, DE, MKFG, KMTUY, SPFR, ROKU, SPLK, KVSB, ADPT, SLGC, VCYT, PSNL, RPTX, ETSY, FTCH, STNE, Z, JD, HEI, BLDE, AVAV
9 Sep 21
Hedge Funds, Trading Ideas, General
UiPath (PATH) - 1,382,967 Shares Invitae (NVTA) - 616,413 Fate Therapeutics (FATE) - 129,739 PagerDuty (PD) - 55,058 Deere & Co (DE) - 37,991 Markforged (MKFG) - 600,664 Komatsu (KMTUY) - 96,118 Jaws
Cathie Wood's ARK Invest Posts Fund Purchases For Friday, Sept. 3, 2021: ROKU, FATE, BLDE, NIU, SPFR, GENI, PFE, RPTX, NVTA, PSNL, ADPT, JD, Z, MKFG
7 Sep 21
Hedge Funds, Trading Ideas, General
Roku (ROKU) - 128,864 Fate Therapeutics (FATE) - 237,809 Blade Air Mobility (BLDE) - 255081 Niu Technologies (NIU) - 4,712 Jaws Spitfire Acquisition Corp (SPFR) - 12,216 Genius
Cathie Wood's ARK Invest Posts Fund Purchases For Thursday, Sept. 2, 2021: FATE, KMTUY, BLDE, MKFG, NNDM, KTOS, NIU, SPFR, GENI, VEEV, PFE, NVTA, PSNL, JD, PDD, Z, TDOC, PRNT
3 Sep 21
Hedge Funds, Trading Ideas, General
Fate Therapeutics (FATE) - 148,263 Shares Komatsu (KMTUY) - 189,578 Blade Air Mobility (BLDE) - 370,118 Markforged (MKFG) - 259,540 Nano Dimension (NNDM) - 197,145 Kratos Defense & Security Solutions (KTOS) -
Cathie Wood's ARK Invest Posts Fund Purchases For Wednesday, Sept. 1, 2021: SGFY, FATE, KMTUY, ACIC, KTOS, KMFG, BLDE, SPFR, GENI, PFE, NVTA, RPTX, PSNL, ADPT, TDOC, Z, PRNT
2 Sep 21
Hedge Funds, Trading Ideas, General
Signify Health (SGFY) - 189,960 Shares Fate Therapeutics (FATE) - 1,075 Komatsu (KMTUY) - 175,000 Atlas Crest Investment (ACIC) - 144,000 Kratos Defense & Security Solutions (KTOS) - 41,408 Markforged (MKFG) -
Cathie Wood's ARK Invest Posts Fund Purchases For Tuesday, Aug. 31, 2021: ZM, VCYT, SGFY, KMTUY, NNDM, KTOS, DDD, NIU, MKFG, BLDE, GENI, FATE, PFE, RPTX, NVTA, PSNL, ADPT, HOOD, STNE, Z, TDOC
1 Sep 21
Hedge Funds, Trading Ideas, General
Zoom Video Communications (ZM) - 194,080 Shares Veracyte (VCYT) - 80,700 Signify Health (SGFY) - 92,717 Komatsu (KMTUY) - 279,686 Nano Dimension (NNDM) - 456,084 Kratos Defense & Security Solutions (KTOS) -
Cathie Wood's ARK Invest Posts Fund Purchases For Monday, Aug. 30, 2021: SGFY, FATE, VCYT, ACIC, DDD, NNDM, MKFG, KTOS, NIU, BLDE, SPFR, PTON, GENI, PFE, NVTA, DYNS, QSI, ADPT, PSNL, RPTX
31 Aug 21
Hedge Funds, Trading Ideas, General
Signify Health (SGFY) - 418,845 Fate Therapeutics (FATE) - 89,825 Veracyte (VCYT) - 3,391 Atlas Crest Investment Corp (ACIC) - 860,704 3D Systems (DDD) - 138,600 Nano Dimensions (NNDM)
Cathie Wood's ARK Invest Posts Fund Purchases For Friday, Aug. 27, 2021: FATE, SGFY, ACIC, KTOS, GENI, PFE, DYNS, RPTX, PSNL, ADPT, QSI, PDD, JD, TDOC, PRNT
30 Aug 21
Hedge Funds, Trading Ideas, General
Fate Therapeutics (FATE) - 172,458 Signify Health (SGFY) - 190,400 Atlas Crest Investment Corp (ACIC) - 190,900 Kratos Defense & Security Solutions (KTOS) - 59,400 Genius Sports
Cathie Wood's ARK Invest Posts Fund Purchases For Thursday, Aug. 26, 2021: NVTA, SGFY, FATE, VCYT, KTOS, ACIC, AVAV, KMTUY, SPLK, GENI, LPSN, PFE, ADPT, BEAM, MASS, PSNL, QSI, CMIIU, RPTX, DYNS, PDD, COIN, PRNT
27 Aug 21
Hedge Funds, Trading Ideas, General
Invitae (NVTA) - 319,045 Shares Signify Health (SGFY) - 178,955 Fate Therapeutics (FATE) - 60,075 Veracyte (VCYT) - 26,653 Kratos Defense & Security Solutions (KTOS) - 201,508 Atlas Crest Investment (ACIC) -
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021
26 Aug 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Cathie Wood's ARK Invest Posts Fund Purchases For Wednesday, Aug. 25, 2021: SGFY, NVTA, FATE, KMTUY, DDD, MKFG, AVAV, KTOS, GENI, LPSN, PFE, QSI, ADPT, PSNL, MASS, CMIIU, DYNS, COIN, TCEHY, TDOC, PDD, JD, Z, ACIC, PRNT
26 Aug 21
Hedge Funds, Trading Ideas, General
Signify Health (SGFY) - 206,099 Shares Invitae (NVTA) - 113,774 Fate Therapeutics (FATE) - 1,000 Komatsu (KMTUY) - 96,487 3D Systems (DDD) - 64,660 Markforged (MKFG) - 383,005 AeroVironment (AVAV) - 3,059 Kratos
Morgan Stanley Initiates Coverage On Fate Therapeutics with Equal-Weight Rating, Announces Price Target of $77
26 Aug 21
News, Price Target, Initiation, Analyst Ratings
Morgan Stanley analyst Michael Ulz initiates coverage on Fate Therapeutics (NASDAQ:FATE) with a Equal-Weight rating and announces Price Target of $77.
Cathie Wood's ARK Invest Posts Fund Purchases For Tuesday, Aug. 24, 2021: DKNG, FATE, SRNG, SGFY, NVTA, KTOS, MKFG, DDD, KMTUY, SPFR, GENI, LPSN, PFE, ADPT, QSI, PSNL, MASS, CMIIU, RPTX, DYNS, Z, TDOC, COIN, PDD, PRNT, ACIC
25 Aug 21
Hedge Funds, Trading Ideas, General
DraftKings (DKNG) - 1,073,171 Shares Fate Therapeutics (FATE) - 529,348 Soaring Eagle Acquisition (SRNG) - 1,197,532 Signify Health (SGFY) - 205,551 Invitae (NVTA) - 49,322 Kratos Defense & Security
Cathie Wood's ARK Invest Posts Fund Purchases For Monday, Aug. 23, 2021: FATE, SRNG, SGFY, VCYT, JD, LMT, PLTR, DDD, MKFG, AVAV, KTOS, SPFR, BLDE, LPSN, GENI, KVSB, PFE, SMFR, QSI, MASS, DYNS, PATH, ACIC, PRNT
24 Aug 21
Hedge Funds, Trading Ideas, General
Fate Therapeutics (FATE) - 207,048 Soaring Eagle Acquisition Corp (SRNG) - 1,178,905 Signify Health (SGFY) - 116,171 Veracyte (VCYT) - 56,871 JD.com (JD) - 164,889 Lockheed
Cathie Wood's ARK Invest Posts Fund Purchases For Friday, Aug. 20, 2021: FATE, SRNG, BEAM, SGFY, TSP, VCYT, PLTR, AVAV, MKFG, BLDE, SPFR, FTCH, GENI, KVSB, LPSN, SMFR, MASS, RPTX, QSI, ZY, PATH
23 Aug 21
Hedge Funds, Trading Ideas, General
Fate Therapeutics (FATE) - 397,896 Soaring Eagle Acquisition Corp (SRNG) - 273,629 Beam Therapeutics (BEAM) - 40,061 Signify Health (SGFY) - 18,900 Tusimple Holdings (TSP) - 1,970 Veracyte (VCYT) -
58 Biggest Movers From Friday
23 Aug 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.
12 Health Care Stocks Moving In Friday's Intraday Session
20 Aug 21
Intraday Update, Markets, Movers
38 Stocks Moving In Friday's Mid-Day Session
20 Aug 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 175% to $17.33. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.

Press releases

Pro users get this 30m faster
Fate Therapeutics Announces Presentations at the Society for Immunotherapy of Cancer 2021 Annual Meeting
1 Oct 21
News, Health Care, Press Releases
SAN DIEGO, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with
Fate Therapeutics to Present at Upcoming Investor Conferences
2 Sep 21
News, Press Releases
SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, today
Fate Therapeutics Announces Positive Interim Clinical Data from its FT596 and FT516 Off-the-shelf, iPSC-derived NK Cell Programs for B-cell Lymphoma
19 Aug 21
News, Health Care, Press Releases, General
10 of 14 Patients in FT596 Single-Dose Escalation Cohorts 2 and 3 Achieved Objective Response; 7 Patients Achieved Complete Response, including 2 of 3 Patients Treated with FT596 in Combination with Rituximab Following
Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress
4 Aug 21
Earnings, Press Releases
First Patient Treated for Relapsed / Refractory ALL in Landmark Phase 1 Clinical Trial of FT819, the First-ever iPSC-derived CAR T-cell Therapy; Off-the-Shelf Product Candidate Derived from Clonal Master iPSC Line with
Fate Therapeutics Announces Treatment of First Patient in Landmark Phase 1 Clinical Trial of FT819, the First-ever iPSC-derived CAR T-Cell Therapy
2 Aug 21
Health Care, Press Releases, General
Off-the-Shelf CAR T-cell Product Candidate Derived from Clonal Master iPSC Line with Novel CD19-specific 1XX CAR Integrated into TRAC Locus Phase 1 Clinical Study will Evaluate Three Dosing Regimens of FT819 for